Literature DB >> 32488477

Impact of postoperative complications on outcomes of second surgery for second primary lung cancer.

Seijiro Sato1, Masaya Nakamura2,3, Yuki Shimizu2, Tatsuya Goto2, Akihiko Kitahara2,4, Terumoto Koike2, Masanori Tsuchida2.   

Abstract

PURPOSE: The best surgical approach for second primary lung cancer remains a subject of debate. The purpose of this study was to review the postoperative complications after second surgery for second primary lung cancer and to investigate the outcomes based on these complications.
METHODS: The clinical data of 105 consecutive patients who underwent pulmonary resection for multiple primary lung cancers between January, 1996 and December, 2017, were reviewed according to the Martini-Melamed criteria.
RESULTS: After the second surgery, low body mass index (BMI) (< 18.5 kg/m2) (P = 0.004) and high Charlson comorbidity index (CCI) (P = 0.002) were independent predictors of postoperative complications. Survival analysis revealed the 5-year overall survival rates of 74.5% and 61.4% for patients without postoperative complications and those with postoperative complications (P = 0.044), respectively, but the 5-year cancer-specific survival rates of 82.5% and 80.0% (P = 0.926), respectively. During this period, there were significantly more respiratory-related deaths of patients with complications than of those without complications (P = 0.011).
CONCLUSION: Surgical intervention is feasible and potentially effective for second primary lung cancer but may not achieve positive perioperative and long-term outcomes for patients with a low BMI or a high CCI. Treatment options should be considered carefully for these patients.

Entities:  

Keywords:  Multiple primary lung cancer; Postoperative complications; Pulmonary resection; Second primary lung cancer

Year:  2020        PMID: 32488477     DOI: 10.1007/s00595-020-02038-y

Source DB:  PubMed          Journal:  Surg Today        ISSN: 0941-1291            Impact factor:   2.549


  2 in total

1.  Outcome and prognosis of secondary lung cancer surgery with interstitial lung disease.

Authors:  Hideomi Ichinokawa; Kazuya Takamochi; Mariko Fukui; Aritoshi Hattori; Takeshi Matsunaga; Kenji Suzuki
Journal:  Thorac Cancer       Date:  2022-05-30       Impact factor: 3.223

2.  Charlson comorbidity index is predictive of postoperative clinical outcome after single-level posterior lumbar interbody fusion surgery.

Authors:  Kensuke Shinonara; Ryo Ugawa; Shinya Arataki; Shinnosuke Nakahara; Kazuhiro Takeuchi
Journal:  J Orthop Surg Res       Date:  2021-03-30       Impact factor: 2.359

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.